Who has invested in Iterum Therapeutics?

single institutional investor are named among the investors backing Iterum Therapeutics.

Iterum Therapeutics Funding: $5M Raised, Series A (2025)

Iterum Therapeutics funding overview

Iterum Therapeutics is based in Chicago. Iterum Therapeutics has raised $5M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in April 2025. The round record for Iterum Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include single institutional investor.

Iterum Therapeutics at a glance

Total raised: $5M
Latest round: Series A
Latest round date: April 2025
Headquarters: Chicago
Notable investors: single institutional investor

Frequently asked about Iterum Therapeutics funding

How much has Iterum Therapeutics raised?: Iterum Therapeutics has raised $5M in total disclosed funding across the rounds on record.
Who has invested in Iterum Therapeutics?: single institutional investor are named among the investors backing Iterum Therapeutics.
What was the latest Iterum Therapeutics funding round?: The most recent disclosed round is a Series A, announced in April 2025.
Where is Iterum Therapeutics based?: Iterum Therapeutics is based in Chicago.
When did Iterum Therapeutics last raise?: The last disclosed Iterum Therapeutics round closed in April 2025 at Series A.

Iterum Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Chicago below to benchmark round size and investor mix.

Iterum Therapeutics Funding: $5M Raised, Series A (2025)

Iterum Therapeutics funding overview

Iterum Therapeutics at a glance

Frequently asked about Iterum Therapeutics funding

Companies related to Iterum Therapeutics (19)

Browse related funding lists (3)